Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Author(s):
Overdijk, M.B.; Verploegen, S.; Bogels, M.; Egmond, M. van; Bueren, J.J.L. van; Mutis, T.; Groen, R.W.J.; Breij, E.; Martens, A.C.M.; Bleeker, W.K.; Parren, P.W.H.I. (0000-0002-4365-3859)
Published
2015
Publication type
Article / Letter to editor
macrophagephagocytosistherapeutic antibodyCD38daratumumabmultiple myelomaBurkitt's lymphoma
Date issued
2015-04-30
Language
English
Is part of
mAbs (2015), Vol. 7, no. 2, p. 311-320
hdl
1887/104013
doi
10.1080/19420862.2015.1007813